CXCR4 WHIM syndrome is a cancer predisposition condition for virus‐induced malignancies
British Journal of Haematology · 2024
DOI: 10.1111/bjh.19373 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Clémentine Moulin und 15 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris-Cité, INSERM U1160, Institut de Recherche Saint-Louis, Paris, France. Hauptthemen laut MEDLINE: Papillomavirus Infections, Epstein-Barr Virus Infections, Warts, Agammaglobulinemia. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Warts, hypogammaglobulinaemia, infections and myelokathexis syndrome (WHIMS) is a rare combined primary immunodeficiency caused by the gain of function of the CXCR4 chemokine receptor. We present the prevalence of cancer in WHIMS patients based on data from the French Severe Chronic Neutropenia Registry and an exhaustive literature review. The median follow‐up of the 14 WHIMS ‘patients was 28.5 years. A central review and viral evaluation of pathological samples were organized, and we conducted a thorough literature review to identify all reports of WHIMS cases. Six French patients were diagnosed with cancer at a median age of 37.6 years. The 40‐year risk of malignancy was 39% (95% confidence interval [CI]: 6%–74%). We observed two human papillomavirus (HPV)‐induced vulvar carcinomas, three lymphomas (two Epstein–Barr virus [EBV]‐related) and one basal cell carcinoma. Among the 155 WHIMS cases from the literature, 22 cancers were reported in 16 patients, with an overall cancer 40‐year risk of 23% (95% CI: 13%–39%). Malignancies included EBV‐associated lymphoproliferative disorders and HPV‐positive genital and anal cancers as in the French cohort. Worldwide, nine cases of malignancy were associated with HPV and four with EBV. Immunocompromised WHIMS patients appear to be particularly susceptible to developing early malignancy, mainly HPV‐induced carcinomas, followed by EBV‐related lymphomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université Paris-Cité, INSERM U1160, Institut de Recherche Saint-Louis, Paris, France.
- Centre de référence des neutropénies chroniques, Registre des neutropénies chroniques, APHP, Hôpital Trousseau Paris, Paris, France.
- Service d'hématologie, Hôpital Necker Enfants Malades, APHP, Paris, France.
- Institut d'hémato oncologie Pédiatrique, Hospice Civil de Lyon, Paris, France.
- Centre de référence des déficits immunitaires héréditaires, Unité d'Immuno-Hématologie Pédiatrique, Hôpital Necker Enfants Malades, APHP, Paris, France.
- Service d'hématologie, CHU Nancy, Nancy, France.
ORCID-Profile: Clémentine Moulin, Jean François Emile, Jean Donadieu
Zitieren
APA
Moulin, C., Beaupain, B., Suarez, F., Bertrand, Y., Beaussant, S. C., Fischer, A., Durin, J., Ranta, D., Espéli, M., Bachelerie, F., Bellanné-Chantelot, C., Molina, T., Emile, J. F., Balabanian, K., Deback, C., & Donadieu, J. (2024). CXCR4 WHIM syndrome is a cancer predisposition condition for virus‐induced malignancies. British Journal of Haematology. https://doi.org/10.1111/bjh.19373
Vancouver
Moulin C, Beaupain B, Suarez F, Bertrand Y, Beaussant SC, Fischer A, et al. CXCR4 WHIM syndrome is a cancer predisposition condition for virus‐induced malignancies. British Journal of Haematology. 2024. doi:10.1111/bjh.19373
BibTeX
@article{Moulin2024,
author = {Moulin, Clémentine and Beaupain, Blandine and Suarez, Felipe and Bertrand, Yves and Beaussant, Sarah Cohen and Fischer, Alain and Durin, Julie and Ranta, Dana and Espéli, Marion and Bachelerie, Françoise and Bellanné-Chantelot, Christine and Molina, Thierry and Emile, Jean François and Balabanian, Karl and Deback, Claire and Donadieu, Jean},
title = {CXCR4 WHIM syndrome is a cancer predisposition condition for virus‐induced malignancies},
journal = {British Journal of Haematology},
year = {2024},
doi = {10.1111/bjh.19373}
}
EUVIMED